Aura Biosciences offers a fully funded ocular oncology play with a Phase 3 upside and limited financing risk. Click to read ...
A major political shakeup looms in Nyanza as alternative political parties launch an aggressive scramble for the region’s ...
Coursera entered this Q3 2026 print already under pressure, with the stock down sharply over the past month and another 25% ...
A $6.3b crypto heist hitting Binance has thrown a harsh spotlight on digital security, counterparty risk and who ultimately ...
PepGen stays a hold, after a major problem with its released data from the phase 2 FREEDOM2-DM1 study using the PGN-EDODM1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results